Tenor Capital Management Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FHLT
Future Health ESG Corp. Common stock
FHLT
|
+$9.81M |
| 2 |
FLYA
SOAR Technology Acquisition Corp.
FLYA
|
+$6.18M |
| 3 |
CONX
CONX Corp. Class A Common Stock
CONX
|
+$6M |
| 4 |
BLTS
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
|
+$5.48M |
| 5 |
AUS
Austerlitz Acquisition Corporation I
AUS
|
+$5.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.75% |
| 2 | Industrials | 1.46% |
| 3 | Technology | 0.72% |
| 4 | Healthcare | 0.62% |
| 5 | Materials | 0.1% |
Similar funds
Tenor Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Tenor Capital Management held 842 positions worth $4.2B, down 3.8% from $4.36B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Tenor Capital Management withdrew a net $3.21B in Q4 2022, closing 210 positions and reducing 2 holdings. Its most notable exit was Future Health ESG Corp. Common stock, an estimated $9.81M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 15% a quarter earlier, followed by Industrials and Technology.
Against the trend, Tenor Capital Management opened a new position in Activision Blizzard worth $1.01M.
- Tenor Capital Management's largest Q4 2022 buy was Activision Blizzard: 13,200 shares worth $1.01M.
- Tenor Capital Management added most to Wag! Group Co Warrant in Q4 2022, an estimated $0 increase.
- Tenor Capital Management's biggest Q4 2022 reduction was Esperion Therapeutics, cutting an estimated $1.21M.
- Tenor Capital Management fully exited Future Health ESG Corp. Common stock in Q4 2022, selling an estimated $9.81M.
- Tenor Capital Management's ten largest holdings make up 31% of its $4.2B portfolio in Q4 2022.
- Tenor Capital Management opened 9 new positions and closed 210 in Q4 2022.
- Tenor Capital Management's portfolio value fell 3.8% quarter-over-quarter to $4.2B.
Based on Tenor Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.